WACKER to Invest Double-Digit Million-Euro Sum in Biotechnology Center
Munich, June 27, 2022 – The WACKER Group is concentrating its biotechnology research activities in Munich. The company is investing a double-digit million-euro sum in the construction of a Biotechnology Center, which is scheduled to be operational in 2024. This investment will strengthen WACKER’s biotechnology business.För mer information se bifogad pressrelease.